Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 1,500
- Avg volume
- 3,578
- Day's range
- $473.67 – $493.27
- Shares out
- —
- Stochastic %K
- 45%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It als...
Show more
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
- Industry
- Drug Manufacturers - General
- Sector
- Healthcare
- Phone
- 41 61 688 88 80
- Website
- https://www.roche.com
- Address
- Grenzacherstrasse 124, Basel, Switzerland
Latest news
No headlines yet.
Stocktwits
Kaythu
Sep 1, 5:45 PM
$RHHVF The next move! This could be great! Start looking inot the acquisition of Modular Medical MODD. Their insulin patch pump looks very promising 🔥🔥🔥🚀🚀🚀
0 replies
GoforProMIS
Aug 19, 4:13 PM
$PMN IMO we have 5-12 pharmaceutical companies interested in PMN:
$BIIB /Eisai due to high Aria of Leqembi.
$RHHVF as the lost bn with Gantenerumab and need a solution.
Abbvie, Bristol Myers, Novartis are keen to get into neurology as partnership.
$PFE and Takeda looking for Episelect Platform!
CEO Neil Warma attended and presented at Jefferies Heathcare, Oppenheimer CNS and at the Bio International Conference with the opportunity of 1to1 meetings.
As the Alzheimer Conference took place on on 12-15 July the 4-6 week NDA analyses by the specialist of pharmaceutical companies should be done.
0 replies
GoforProMIS
Jul 16, 11:06 AM
$PMN Big Pharma is buying up small fishes for
$2,8 bn.
If 1 of the big
$LLY $BIIB or
$ESALY or
$RHHVF starts a bidding war we should see a nice run at least to MCap 1bn in the coming weeks
0 replies
GoforProMIS
Jul 14, 10:25 AM
$PMN with best in class results at the Alzheimer’s Association International Conference (AAIC) as the world’s largest and most important professional conference dedicated to Alzheimer’s and dementia research.
Key figures:
Around 12,000 participants from across the globe attended AAIC 2025.
Of these, over 8,000 attended in person, while more than 3,000 joined online.
Participants came from 139 countries.
Participants include:
Neurologists
Alzheimer’s researchers Representatives from universities Pharmaceutical companies
$LLY ,
$BIIB ,
$RHHVF ,
$ESALY , etc.
Investors and biotech analysts
FDA and regulatory representatives Clinical trial investigators.
Get ready for amazing day, week and months to come 🚀
https://www.promisneurosciences.com/investors/news-events/press-releases/detail/269/promis-neurosciences-reports-first-human-evidence-of
0 replies
trenddetector
Apr 2, 6:18 PM
$RHHVF Share this site with anyone that has cancer and is searching for options. A great resource for those confused about approved treatments and trials that are enrolling. https://nimble-frangollo-81ff5e.netlify.app/#
0 replies
